Adamantan-2-Ol

Adamantan-2-Ol

SCHEMBL8345108

OC12CC3CC(CC(C3)C1)C2.OC1C2CC3CC(C2)CC1C3

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.65
PKM P14618 1/20 0.37
EPHX2 P34913 4/20 0.34
HSD11B1 P28845 5/20 0.33
HSD11B2 P80365 2/20 0.33
LMNA P02545 2/20 0.32
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
STAT6 P42226 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
SLC47A1 Q96FL8 1/20 0.32
SIGMAR1 Q99720 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1772242 0.87 CYP2C9 (0.46) CYP2C9PKMEPHX2HSD11B1HSD11B2
Adamantan-2-Ol SCHEMBL9228492 0.84 CYP2C9 (0.46) CYP2C9EPHX2HSD11B1HSD11B2TSHR
Adamantane SCHEMBL8487115 0.84 PKM (0.46) CYP2C9PKMEPHX2HSD11B1LMNA
SCHEMBL12837800 0.82 CYP2C9 (0.39) CYP2C9PKMEPHX2HSD11B1HSD11B2
SCHEMBL23333268 0.81 PKM (0.48) PKMEPHX2LMNASLC22A2SLC22A1
SCHEMBL148421 0.81 PKM (0.48) PKMEPHX2LMNASLC22A2SLC22A1
SCHEMBL1150449 0.81 PKM (0.48) PKMEPHX2LMNASLC22A2SLC22A1
SCHEMBL2126658 0.81 PKM (0.48) PKMEPHX2LMNASLC22A2SLC22A1
Adamantan-2-Ol SCHEMBL350390 0.81 CYP2C9 (1.00) CYP2C9EPHX2HSD11B1SIGMAR1
Adamantan-2-Ol SCHEMBL8931261 0.81 CYP2C9 (1.00) CYP2C9EPHX2HSD11B1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999012572-A1 COMPOUNDS AND METHOD FOR THE PREVENTION AND TREATMENT OF DIABETIC RETINOPATHY UNIVERSITY OF FLORIDA (US) 1999-03-18 WO disclosed
EP-0661986-A4 BRAIN-ENHANCED DELIVERY OF NEUROACTIVE PEPTIDES BY SEQUENTIAL METABOLISM. UNIV FLORIDA (US) 1997-04-23 EP disclosed
EP-0661986-A1 BRAIN-ENHANCED DELIVERY OF NEUROACTIVE PEPTIDES BY SEQUENTIAL METABOLISM UNIVERSITY OF FLORIDA (US) 1995-07-12 EP disclosed
WO-1994006450-A1 BRAIN-ENHANCED DELIVERY OF NEUROACTIVE PEPTIDES BY SEQUENTIAL METABOLISM UNIVERSTIY OF FLORIDA (US) 1994-03-31 WO disclosed